These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

586 related items for PubMed ID: 17867914

  • 21. Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor.
    Buczko W, Hermanowicz JM.
    Pharmacol Rep; 2008; 60(5):623-31. PubMed ID: 19066408
    [Abstract] [Full Text] [Related]

  • 22. Direct renin inhibition with aliskiren in hypertension and target organ damage.
    Müller DN, Luft FC.
    Clin J Am Soc Nephrol; 2006 Mar; 1(2):221-8. PubMed ID: 17699210
    [Abstract] [Full Text] [Related]

  • 23. Direct inhibition of renin as a cardiovascular pharmacotherapy: focus on aliskiren.
    Sepehrdad R, Frishman WH, Stier CT, Sica DA.
    Cardiol Rev; 2007 Mar; 15(5):242-56. PubMed ID: 17700383
    [Abstract] [Full Text] [Related]

  • 24. Is there a future for direct renin inhibitors?
    Chaudhary K, Nistala R, Whaley-Connell A.
    Expert Opin Investig Drugs; 2010 May; 19(5):653-61. PubMed ID: 20380486
    [Abstract] [Full Text] [Related]

  • 25. Clinical role of direct renin inhibition in hypertension.
    Taylor AA, Pool JL.
    Am J Ther; 2012 May; 19(3):204-10. PubMed ID: 21317620
    [Abstract] [Full Text] [Related]

  • 26. [Advantages and limitations of renin inhibition with aliskiren].
    Azizi M, Frank M, Steichen O, Blanchard A.
    Ann Pharm Fr; 2011 May; 69(3):142-50. PubMed ID: 21570538
    [Abstract] [Full Text] [Related]

  • 27. [Renin and the heart].
    Ural D, Cetin M.
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():23-7. PubMed ID: 20019473
    [Abstract] [Full Text] [Related]

  • 28. [Renin inhibition and the kidney].
    Ecder T.
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
    [Abstract] [Full Text] [Related]

  • 29. Aliskiren for renin inhibition: a new class of antihypertensives.
    Van Tassell BW, Munger MA.
    Ann Pharmacother; 2007 Mar; 41(3):456-64. PubMed ID: 17341529
    [Abstract] [Full Text] [Related]

  • 30. Aliskiren, the first approved renin inhibitor: Clinical application and safety in the treatment of hypertension.
    Riccioni G, Vitulano N, D'Orazio N, Bellocci F.
    Adv Ther; 2009 Jul; 26(7):700-10. PubMed ID: 19649581
    [Abstract] [Full Text] [Related]

  • 31. Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension.
    Doulton TW, MacGregor GA.
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):185-9. PubMed ID: 19617273
    [Abstract] [Full Text] [Related]

  • 32. [Direct renin inhibitor aliskiren in the treatment of cardiovascular and renal diseases].
    Horký K.
    Vnitr Lek; 2010 Feb; 56(2):120-6. PubMed ID: 20329582
    [Abstract] [Full Text] [Related]

  • 33. Aliskiren: renin inhibitor for hypertension management.
    Cheng JW.
    Clin Ther; 2008 Jan; 30(1):31-47. PubMed ID: 18343241
    [Abstract] [Full Text] [Related]

  • 34. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V, Buksa M, Loza V, Kulic M.
    Med Arh; 2009 Jan; 63(6):343-9. PubMed ID: 20380117
    [Abstract] [Full Text] [Related]

  • 35. Direct renin inhibitors as antihypertensive agents.
    Israili ZH, Velasco M, Bermúdez V.
    Am J Ther; 2010 Jan; 17(3):237-54. PubMed ID: 20479579
    [Abstract] [Full Text] [Related]

  • 36. [Renin as a target of direct pharmacological block in arterial hypertension].
    Mukhin NA, Fomin VV.
    Ter Arkh; 2009 Jan; 81(8):5-9. PubMed ID: 19799192
    [Abstract] [Full Text] [Related]

  • 37. [Renal protection in the patients with idiopathic hypertensia: the possibilities of the combined blockade of the reninangiotensinaldosterone system].
    Kachnov VA, Tyrenko VV, Nikitin AÉ, Sinopal'nikov DO, Kol'tsov AV.
    Voen Med Zh; 2010 Aug; 331(8):20-4. PubMed ID: 21089428
    [Abstract] [Full Text] [Related]

  • 38. Aliskiren: beyond blood pressure reduction.
    Riccioni G, Vitulano N, Zanasi A, Bellocci F, d'Orazio N.
    Expert Opin Investig Drugs; 2010 Oct; 19(10):1265-74. PubMed ID: 20812878
    [Abstract] [Full Text] [Related]

  • 39. [Renin inhibition in hypertension].
    Güleç S.
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():15-22. PubMed ID: 20019472
    [Abstract] [Full Text] [Related]

  • 40. Long-term safety, tolerability, and antihypertensive efficacy of aliskiren, an oral direct renin inhibitor, in Japanese patients with hypertension.
    Kushiro T, Itakura H, Abo Y, Gotou H, Terao S, Keefe DL.
    Hypertens Res; 2009 Mar; 32(3):169-75. PubMed ID: 19262478
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 30.